ABSTRACT Background The transition through menopause is accompanied by a series of adverse metabolic changes which are associated with an increased risk of cardiometabolic disease, a major cause of mortality in women after midlife. Whilst the indication for menopausal hormone replacement therapy (HRT) is the control of menopausal symptoms ...
Jiawen Dong +5 more
wiley +1 more source
Association between the cardiometabolic index and all-cause and cardiovascular mortality in diabetes and prediabetes. [PDF]
Wang Y +4 more
europepmc +1 more source
Pregnancy Outcomes Among Individuals With Cerebral Palsy: A Population‐Based Cohort Study
ABSTRACT Objective To examine the risks of maternal, neonatal and non‐obstetrical medical complications in individuals with cerebral palsy (CP) compared to those without CP. Design Population‐based cohort study. Setting Ontario, Canada. Population Females aged 13–54 years with a livebirth or stillbirth, 2004–2023.
Marina Vainder +3 more
wiley +1 more source
ABSTRACT Background Psychotropic medications are associated with serious metabolic adverse effects, which contribute to an increased risk of cardiometabolic comorbidities in patients with severe mental illness (SMI). Several intervention strategies are available to mitigate these metabolic adverse effects; however, data on their utility in real‐world ...
Nicolette Stogios +17 more
wiley +1 more source
Association between cardiometabolic index and stroke risk: insights from the CHARLS cohort study. [PDF]
Liu T +6 more
europepmc +1 more source
What anabolic–androgenic steroids reveal about the limits of current harm reduction models
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski +2 more
wiley +1 more source
Association of cardiometabolic index with non-alcoholic fatty liver disease among Iranian adults of the amol cohort study. [PDF]
Behzad C +8 more
europepmc +1 more source
Cardiometabolic index as a predictor of gallstone risk: evidence from NHANES 2017-2020. [PDF]
Zheng H +9 more
europepmc +1 more source
Relationship Between Cardiometabolic Index and Post-PCI Coronary Microvascular Dysfunction in Acute STEMI Patients. [PDF]
Sha X, Wang W, Wang J, Wang R.
europepmc +1 more source
Association between cardiometabolic index and cardiovascular disease: evidence From the NHANES 2007-2018. [PDF]
Chen F +7 more
europepmc +1 more source

